Altria pays $235 million to settle Juul lawsuits

May.11.2023
Altria pays $235 million to settle Juul lawsuits
Altria Group has agreed to pay $235 million to settle lawsuits related to its investment in Juul and youth vaping.

On May 10th, according to a report from Reuters, Altria Group announced it will pay $235 million to settle at least 6,000 lawsuits accusing the company of encouraging teenage e-cigarette use by investing in Juul, a leading e-cigarette manufacturer.


This deal settled nearly all lawsuits brought against Altria by local government agencies and individuals across the United States related to Juul. Altria anticipates recording a pre-tax charge of $235 million in the second quarter of 2023 and intends to exclude this charge from adjusted earnings per share.


Sarah London, one of the lead lawyers for the plaintiff, stated in a written statement regarding the settlement that it would provide "unprecedented and truly meaningful relief for youth, parents, and government organizations nationwide.


Murray Garnick, Altria's Executive Vice President and General Counsel, recently said that the claims against Altria are unfounded. However, he believes that settling the matter would be in the best interest of the company's shareholders.


However, we believe this resolution avoids the uncertainty and costs of lengthy legal proceedings, and is in the best interests of our shareholders.


The plaintiff in the lawsuit alleges that Juul employed inappropriate methods (such as promoting flavored e-cigarettes and utilizing internet and social media campaigns) to market their products to minors, and that Altria assisted Juul's marketing efforts by allowing them to use their sales team and display their products on shelves next to Altria's own products.


Altria has announced that it has relinquished its 35% stake in Juul. As of December 2022, its stake in Juul was worth $250 million, down from the $12.8 billion it invested in 2018.


Juul has reached settlements in the majority of its cases, paying over $1 billion to 48 states and territories, as well as $1.7 billion to individual and local government entities.


Beth Wilkinson, lawyer for Altria, stated in a recent lawsuit that the company did not benefit from its investment in JUUL.


This investment of 12.8 billion dollars did not result in any returns, and Altria did not benefit from it in any way.


References:


Altria has agreed to pay $235 million in order to settle all cases related to Juul, the vaping giant in which the cigarette maker has a 35% stake. This settlement will end all lawsuits that have been filed against Altria over Juul-related issues.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
British American Tobacco (BAT) reaffirmed its 2026 guidance while announcing a £1.3 billion (approximately USD 1.65 billion) share buyback for FY26. The company expects around 2% growth in revenue and adjusted profit from operations for FY25. Accelerating New Category growth, driven by Velo Plus and improving U.S. Vuse performance, is expected to deliver double-digit H2 revenue growth.
Dec.09 by 2FIRSTS.ai
RFK Jr. Says Public Should Not Follow His Personal Use of Zyn Nicotine Pouches
RFK Jr. Says Public Should Not Follow His Personal Use of Zyn Nicotine Pouches
According to People, U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said in an interview with The Atlantic that although he frequently uses Zyn nicotine pouches, he does not recommend that Americans imitate his personal habits. His use of nicotine products has drawn renewed attention, alongside ongoing scrutiny of his broader health-related positions.
Dec.04
EU to consider Denmark's proposal for stricter tobacco tax reforms. Heating tobacco tax could increase by 132%, nicotine pouch tax by up to 1000%. 92% opposed to overall tax hike in public consultation. Concerns raised over taxing innovative smoke-free pr
EU to consider Denmark's proposal for stricter tobacco tax reforms. Heating tobacco tax could increase by 132%, nicotine pouch tax by up to 1000%. 92% opposed to overall tax hike in public consultation. Concerns raised over taxing innovative smoke-free pr
EU to debate Denmark's proposal to increase tobacco taxes, including a 132% hike for heated tobacco and 1000% for nicotine pouches.
Dec.04 by 2FIRSTS.ai
Russian Region Targets Youth Vaping and Night Alcohol Sales
Russian Region Targets Youth Vaping and Night Alcohol Sales
The Speaker of the Legislative Assembly of Russia’s Nizhny Novgorod Region said efforts to curb night-time alcohol sales and the spread of e-cigarettes will continue in 2026. While illegal alcohol trade has largely been eliminated, youth vaping remains a major concern. Regional authorities are seeking federal approval to allow local governments to impose stricter restrictions on vape sales, alongside increased health education initiatives.
Dec.22 by 2FIRSTS.ai
U.S. Fifth Circuit judges question FDA’s claim it has no de facto ban on flavored refillable e-cigarettes
U.S. Fifth Circuit judges question FDA’s claim it has no de facto ban on flavored refillable e-cigarettes
Law360 reports that a Fifth Circuit panel expressed skepticism about the FDA’s claim that it has no de facto ban on flavored refillable e-cigarette products, noting that only six applications had been approved out of hundreds of thousands and that near-100% denials look like a ban.
Jan.07 by 2FIRSTS.ai
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai